(283 days)
Not Found
Not Found
No
The summary describes a pre-filled syringe for flushing, with no mention of AI/ML terms, image processing, or data-driven performance metrics typically associated with AI/ML devices.
No.
The device is used for flushing IV tubing, which is a supportive function but not a direct therapeutic intervention for a disease or condition. Its purpose is to maintain patency rather than treat.
No
The device is described as a pre-filled syringe with saline solution used for flushing intravenous tubing and access devices, which is a therapeutic or maintenance function, not a diagnostic one. There is no mention of it being used to detect, diagnose, treat, or prevent any disease or condition.
No
The device description explicitly states it consists of "plastic syringes aseptically filled with sterile 0.9% sodium chloride solution," which are physical hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for flushing intravenous tubing systems and indwelling intravascular access devices. This is a direct interaction with the patient's circulatory system for maintenance and preparation, not for testing a sample in vitro (outside the body).
- Device Description: The device is a pre-filled syringe with saline solution. This is a medical device used for administration or flushing, not for performing a diagnostic test on a biological sample.
- Lack of IVD Characteristics: The description does not mention any components or functions related to analyzing biological samples (like blood, urine, tissue, etc.) to diagnose a condition, monitor treatment, or screen for diseases.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic purposes. This device's function is purely mechanical/fluidic for maintaining IV lines.
N/A
Intended Use / Indications for Use
The 0.9% Sodium Chloride Flush Syringe is indicated for use in flushing compatible intravenous tubing systems and indwelling intravascular access devices.
Product codes
FOZ
Device Description
The proposed device consists of various sizes and fill volumes of plastic syringes aseptically filled with sterile 0.9% sodium chloride solution.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Test data have been generated for stability and container/closure suitability. Performance testing indicates that the proposed device meets or exceeds all functional requirements and supports its suitability for use.
Key Metrics
Not Found
Predicate Device(s)
Abbott prefilled syringe with 0.9% sodium chloride solution
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5200 Intravascular catheter.
(a)
Identification. An intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings and that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. The device may be constructed of metal, rubber, plastic, or a combination of these materials.(b)
Classification. Class II (performance standards).
0
984590
OCT 7 1999
510(k) Premarket Notification 0.9% Sodium Chloride Flush Syringe
510(k) SUMMARY
Submitted by:
Marcia Marconi Baxter Healthcare Corporation I.V. Systems Division Rte. 120 and Wilson Road Round Lake, IL 60073
Date Prepared: December 24, 1998
Proposed Device:
The proposed device consists of various sizes and fill volumes of plastic syringes aseptically filled with sterile 0.9% sodium chloride solution.
Predicate Device:
The predicate device is the Abbott prefilled syringe with 0.9% sodium chloride solution.
Proposed Device Description:
The proposed device consists of various sizes and fill volumes of plastic syringes aseptically filled with sterile 0.9% sodium chloride solution.
Statement of Intended Use:
The device is intended for use in flushing compatible intravenous tubing systems and indwelling intravascular access devices.
Summary of Technological Characteristics of New Device Compared to Predicate Devices
The proposed device has the same technological characteristics as the predicate device. Both consist of plastic syringes containing sterile 0.9% sodium chloride solution.
Discussion of Nonclinical Tests; Conclusions Drawn from Nonclinical Tests
Test data have been generated for stability and container/closure suitability. Performance testing indicates that the proposed device meets or exceeds all functional requirements and supports its suitability for use.
DEC 2 4 1998
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized emblem featuring three abstract human profiles facing to the right, stacked on top of each other.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 7 1999
Ms. Marcia Marconi Vice President, Regulatory Affairs I.V. Systems Division Regulatory Affairs Baxter Healthcare Corporation Route 120 & Wilson Road Round Lake, Illinois 60073-0490
Re : K984590 0.9% Sodium Chloride Flush Syringe Trade Name: Regulatory Class: II Product Code: FOZ Dated: July 29, 1999 Received: August 2, 1999
Dear Ms. Marconi:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Druq, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, qood manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) requlation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any
2
Page 2 - Ms. Marconi
obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510 k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Timothy A. Ulatowski
Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
510(k) Premarket Notification 0.9% Sodium Chloride Flush Syringe
Not Available 510(k) Number:
0.9% Sodium Chloride Flush Syringe Device Name:
Indication for Use:
The 0.9% Sodium Chloride Flush Syringe is indicated for use in flushing compatible intravenous tubing systems and indwelling intravascular access devices.
Palucca Crescent
Prescription USE ✓
(Per 21 CFR 801.109)
DEC 2 4